Center for Scientific Review; Notice of Closed Meetings, 56758 [2024-15112]
Download as PDF
<![CDATA[
56758
Federal Register / Vol. 89, No. 132 / Wednesday, July 10, 2024 / Notices
II. Topics for Discussion at the Public
Workshop
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
At the public workshop, FDA plans to
convene experts in AI to discuss topics,
including but not limited to:
1. Optimizing model design through
multidisciplinary expertise.
Specifically, discussants will explore
the importance of integrating experts
from diverse fields, such as medicine,
statistics, pharmacology, data science,
and engineering to ensure the
development of optimal AI models.
2. Exploring strategies for overcoming
common data-related challenges,
namely, the availability of fit-for-use
data that can be used in drug
development. Topics will include data
availability and access via federated
learning, data quality issues (i.e.,
representativeness of data, bias, etc.),
and the use of synthetic data.
3. Balancing model performance,
explainability, and transparency of AI
models. Additionally, discussants will
share strategies for assessing the need to
integrate humans into the decisionmaking process (human-in-the-loop
and/or human-on-the-loop).
4. Identifying key gaps and challenges
hindering the use of AI in drug and
biological product development and
exploring potential strategies,
collaborations, and initiatives to address
these challenges. Considering actionable
next steps to advance the responsible
use of AI in developing safe, effective,
and quality drugs.
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
III. Participating in the Public
Workshop
Registration: To register for the public
workshop, please visit the following
website: https://duke.zoom.us/meeting/
register/tJcrcuqrTMiHdayh1J3JhkCi6XkvmAIFey6.
Please provide complete contact
information for each attendee, including
name, title, affiliation, address, email,
and telephone.
Registration is free and people
interested in attending this public
workshop must register to receive a link
to the meeting. Registrants will receive
confirmation email after they register.
If you need special accommodations
due to a disability, please contact
Kelly.Franzetti@duke.edu no later than
July 30, 2024. Please note, closed
captioning will be available
automatically.
Dated: July 5, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–15125 Filed 7–9–24; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
18:33 Jul 09, 2024
Jkt 262001
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Metabolism.
Date: August 2, 2024.
Time: 12:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics on HIV Comorbidities,
Coinfections and Associated Cancers.
Date: August 5, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raul Rojas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
Bethesda, MD 20892, (301) 451–6319, rojasr@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
Date: August 6–7, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 5, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–15112 Filed 7–9–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Metabolism.
Date: July 26, 2024.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Hypersensitivity,
Autoimmunity and Immune-mediated
Diseases.
Date: August 2, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4203,
Bethesda, MD 20892, (301) 435–3566,
mulkya@mail.nih.gov.
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 89, Number 132 (Wednesday, July 10, 2024)]
[Notices]
[Page 56758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15112]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business Metabolism.
Date: August 2, 2024.
Time: 12:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435-
1154, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics on HIV Comorbidities, Coinfections
and Associated Cancers.
Date: August 5, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raul Rojas, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6185, Bethesda, MD 20892, (301) 451-6319,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Respiratory Sciences.
Date: August 6-7, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187, MSC 7804, Bethesda, MD
20892, 301-451-0132, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: July 5, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-15112 Filed 7-9-24; 8:45 am]
BILLING CODE 4140-01-P
